Variant report

Variant	nsv879009
Chromosome Location	chr4:48476539-48494546
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:297)
CpG islands
(count:1893)
Chromatin interactive
region (count:15)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:297 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:48477763-48478047	K562	blood:	n/a	n/a
2	ARID3A	chr4:48483723-48484037	K562	blood:	n/a	n/a
3	ARID3A	chr4:48484962-48485247	K562	blood:	n/a	n/a
4	ARID3A	chr4:48487020-48487153	K562	blood:	n/a	n/a
5	ATF1	chr4:48483638-48483988	K562	blood:	n/a	n/a
6	BACH1	chr4:48485777-48486288	H1-hESC	embryonic stem cell:	n/a	n/a
7	BACH1	chr4:48485381-48485382	H1-hESC	embryonic stem cell:	n/a	n/a
8	BACH1	chr4:48493250-48493536	H1-hESC	embryonic stem cell:	n/a	n/a
9	BACH1	chr4:48486855-48487010	H1-hESC	embryonic stem cell:	n/a	n/a
10	BHLHE40	chr4:48486934-48487121	K562	blood:	n/a	n/a
11	BHLHE40	chr4:48485470-48485714	K562	blood:	n/a	chr4:48485560-48485576
12	BHLHE40	chr4:48477903-48478176	K562	blood:	n/a	n/a
13	BHLHE40	chr4:48483691-48483965	K562	blood:	n/a	n/a
14	CBX3	chr4:48485746-48486116	K562	blood:	n/a	n/a
15	CBX3	chr4:48483613-48484010	K562	blood:	n/a	n/a
16	CCNT2	chr4:48485129-48486088	K562	blood:	n/a	n/a
17	CCNT2	chr4:48477848-48478194	K562	blood:	n/a	n/a
18	CCNT2	chr4:48483694-48483987	K562	blood:	n/a	n/a
19	CCNT2	chr4:48486352-48486939	K562	blood:	n/a	n/a
20	CCNT2	chr4:48492468-48492539	K562	blood:	n/a	n/a
21	CEBPB	chr4:48483480-48483916	K562	blood:	n/a	chr4:48483581-48483594 chr4:48483583-48483594
22	CEBPB	chr4:48490809-48491079	HepG2	liver:	n/a	chr4:48490992-48491003
23	CEBPB	chr4:48490836-48490940	K562	blood:	n/a	n/a
24	CEBPD	chr4:48483548-48484092	K562	blood:	n/a	n/a
25	CEBPD	chr4:48483530-48484088	K562	blood:	n/a	n/a
26	CHD2	chr4:48483568-48483726	K562	blood:	n/a	n/a
27	CHD2	chr4:48478980-48479020	K562	blood:	n/a	n/a
28	CHD2	chr4:48485558-48485586	K562	blood:	n/a	n/a
29	CHD2	chr4:48493281-48493570	H1-hESC	embryonic stem cell:	n/a	n/a
30	CHD2	chr4:48486715-48486814	H1-hESC	embryonic stem cell:	n/a	n/a
31	CREB1	chr4:48485290-48485607	A549	lung:	n/a	n/a
32	CREB1	chr4:48485358-48485716	H1-hESC	embryonic stem cell:	n/a	n/a
33	CTBP2	chr4:48491559-48494045	H1-hESC	embryonic stem cell:	n/a	n/a
34	CTBP2	chr4:48485327-48486322	H1-hESC	embryonic stem cell:	n/a	n/a
35	CTCF	chr4:48485940-48486090	AG04449	skin:	n/a	n/a
36	CTCF	chr4:48486200-48486350	SK-N-SH_RA	brain:	n/a	chr4:48486338-48486346 chr4:48486337-48486345
37	CTCF	chr4:48485878-48486008	GM19239	blood:	n/a	n/a
38	CTCF	chr4:48484452-48484645	K562	blood:	n/a	chr4:48484482-48484490
39	CTCF	chr4:48478920-48479070	HBMEC	blood vessel:	n/a	n/a
40	CTCF	chr4:48485882-48486279	K562	blood:	n/a	n/a
41	CTCF	chr4:48485696-48486186	K562	blood:	n/a	n/a
42	CTCF	chr4:48486140-48486290	BE2_C	brain:	n/a	n/a
43	CTCF	chr4:48485933-48485975	NHEK	skin:	n/a	n/a
44	CTCF	chr4:48485960-48486110	K562	blood:	n/a	n/a
45	CTCF	chr4:48485843-48486023	Fibrobl	skin:	n/a	n/a
46	CTCF	chr4:48485909-48486031	K562	blood:	n/a	n/a
47	CTCF	chr4:48485920-48486070	GM12871	blood:	n/a	n/a
48	CTCF	chr4:48485920-48486070	GM12867	blood:	n/a	n/a
49	CTCF	chr4:48492140-48492290	GM12866	blood:	n/a	n/a
50	CTCF	chr4:48485890-48486021	H1-hESC	embryonic stem cell:	n/a	n/a

(count:1893 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:48485301-48485351	NB4	blood:	n/a
2	chr4:48485233-48485283	PFSK-1	brain:	n/a
3	chr4:48485301-48485351	NB4	blood:	n/a
4	chr4:48485233-48485283	PFSK-1	brain:	n/a
5	chr4:48483244-48483294	PrEC	prostate:	n/a
6	chr4:48484788-48484838	Hela-S3	cervix:	n/a
7	chr4:48486154-48486204	T-47D	breast:	n/a
8	chr4:48492845-48492895	HMEC	breast:	n/a
9	chr4:48489221-48489271	HNPCEpiC	eye:	n/a
10	chr4:48492845-48492895	IMR90	lung:	fetal
11	chr4:48484997-48485047	HCT-116	colon:	n/a
12	chr4:48492845-48492895	U87	brain:	n/a
13	chr4:48493846-48493896	LNCaP	prostate:	n/a
14	chr4:48484997-48485047	PANC-1	pancreas:	n/a
15	chr4:48486154-48486204	HepG2	liver:	n/a
16	chr4:48485289-48485339	A549	lung:	n/a
17	chr4:48485289-48485339	NH-A	brain:	n/a
18	chr4:48486154-48486204	GM12891	blood:	n/a
19	chr4:48492848-48492898	MCF10A-Er-Src	breast:	n/a
20	chr4:48485289-48485339	ovcar-3	ovarian:	n/a
21	chr4:48485624-48485674	ovcar-3	ovarian:	n/a
22	chr4:48485293-48485343	AG04450	lung:	fetal
23	chr4:48485301-48485351	SAEC	small airway:	n/a
24	chr4:48493846-48493896	HUVEC	blood vessel:	n/a
25	chr4:48486472-48486522	AG09319	gingival:	n/a
26	chr4:48485306-48485356	NHDF-neo	bronchial:	n/a
27	chr4:48491968-48492018	GM06990	blood:	n/a
28	chr4:48492118-48492168	HL-60	blood:	n/a
29	chr4:48483244-48483294	HEK293	kidney:	embryo
30	chr4:48485306-48485356	HCT-116	colon:	n/a
31	chr4:48485306-48485356	IMR90	lung:	fetal
32	chr4:48486785-48486835	Jurkat	blood:	n/a
33	chr4:48492122-48492172	AG10803	skin:	n/a
34	chr4:48492118-48492168	K562	blood:	n/a
35	chr4:48486472-48486522	HCF	heart:	n/a
36	chr4:48493350-48493400	HRPEpiC	eye:	n/a
37	chr4:48492845-48492895	HL-60	blood:	n/a
38	chr4:48489221-48489271	GM12892	blood:	n/a
39	chr4:48492848-48492898	SK-N-MC	brain:	n/a
40	chr4:48484997-48485047	MCF-7	breast:	n/a
41	chr4:48492118-48492168	PrEC	prostate:	n/a
42	chr4:48486154-48486204	HMEC	breast:	n/a
43	chr4:48485301-48485351	CMK	blood:	n/a
44	chr4:48492118-48492168	ECC-1	luminal epithelium:	n/a
45	chr4:48484788-48484838	AG09309	skin:	n/a
46	chr4:48486785-48486835	HCM	heart:	n/a
47	chr4:48489221-48489271	GM12878	blood:	n/a
48	chr4:48486316-48486366	NHDF-neo	bronchial:	n/a
49	chr4:48485090-48485140	AG09319	gingival:	n/a
50	chr4:48489221-48489271	CMK	blood:	n/a

(count:15 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:48477174..48479386-chr4:48484669..48486658,3	K562	blood:
2	chr4:48474711..48478093-chr4:48481760..48484353,3	K562	blood:
3	chr4:48489612..48492154-chr4:48493154..48495602,2	K562	blood:
4	chr4:48478067..48481410-chr4:48493413..48496125,3	K562	blood:
5	chr4:48474711..48478093-chr4:48481760..48484353,3	K562	blood:
6	chr4:48341909..48343469-chr4:48483589..48486077,2	K562	blood:
7	chr4:48473818..48475564-chr4:48478853..48480558,2	K562	blood:
8	chr4:48478979..48481680-chr4:48482843..48484535,2	K562	blood:
9	chr4:48492886..48494734-chr4:48535449..48537970,2	K562	blood:
10	chr4:48341467..48343836-chr4:48476769..48479508,2	K562	blood:
11	chr4:48485954..48488857-chr4:48528912..48531083,2	K562	blood:
12	chr4:48489612..48492154-chr4:48493154..48495602,2	K562	blood:
13	chr4:48478979..48481680-chr4:48482843..48484535,2	K562	blood:
14	chr4:48478067..48481410-chr4:48493413..48496125,3	K562	blood:
15	chr4:48484114..48487251-chr4:48504187..48509460,5	K562	blood:

No data

Variant related genes	Relation type
SLC10A4	TF binding region
ZAR1	TF binding region
SLC10A4	CpG island
ZAR1	CpG island
ENSG00000145248	chromatin interactions
ENSG00000075539	chromatin interactions
ENSG00000109171	chromatin interactions

Extended variants
information (count: 596 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:596 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6838613	chr4:48476539-48476540	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs73814762	chr4:48476550-48476551	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs115001750	chr4:48476650-48476651	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs569748600	chr4:48476697-48476698	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs151110269	chr4:48476699-48476700	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs73814763	chr4:48476710-48476711	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs376873227	chr4:48476747-48476748	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs567431337	chr4:48476776-48476777	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs76105157	chr4:48476813-48476814	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs571098794	chr4:48476825-48476826	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs552939618	chr4:48476834-48476835	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs149815826	chr4:48476926-48476927	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs200413446	chr4:48476952-48476953	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs545011619	chr4:48476953-48476954	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs540283815	chr4:48477054-48477055	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs557273454	chr4:48477145-48477146	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs180984199	chr4:48477163-48477164	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs542657572	chr4:48477194-48477195	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs560824145	chr4:48477217-48477218	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs147803678	chr4:48477247-48477248	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs141182710	chr4:48477259-48477260	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs559736857	chr4:48477295-48477296	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs533553141	chr4:48477298-48477299	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs551683833	chr4:48477342-48477343	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs146933655	chr4:48477373-48477374	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs186164377	chr4:48477483-48477484	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs145230790	chr4:48477485-48477486	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs548968900	chr4:48477624-48477625	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs12646957	chr4:48477660-48477661	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs147573437	chr4:48477688-48477689	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs534848902	chr4:48477732-48477733	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs149026946	chr4:48477748-48477749	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs571383644	chr4:48477771-48477772	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs538860299	chr4:48477804-48477805	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs190278335	chr4:48477811-48477812	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs115904689	chr4:48477812-48477813	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs181410216	chr4:48477824-48477825	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs554649519	chr4:48477825-48477826	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs572788358	chr4:48477827-48477828	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs550723942	chr4:48477837-48477838	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs13111419	chr4:48477876-48477877	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs112867907	chr4:48477920-48477921	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs143208979	chr4:48477928-48477929	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs186082378	chr4:48477956-48477957	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs545207857	chr4:48478001-48478002	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs6447639	chr4:48478002-48478003	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs7693468	chr4:48478013-48478014	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs555918409	chr4:48478023-48478024	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs575760326	chr4:48478047-48478048	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs190752447	chr4:48478059-48478060	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
Oral squamous cell carcinoma	17134496	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	22183965	CNVD
Cancer	22183965	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	22522925	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
small cell lung cancer	20016488	CNVD

Chromatin state (count:632 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:48473000-48482000	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr4:48473000-48483600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr4:48473600-48479400	Weak transcription	Cortex derived primary cultured neurospheres	brain
4	chr4:48477600-48478600	Enhancers	K562	blood
5	chr4:48478000-48478200	Enhancers	Skeletal Muscle Male	skeletal muscle
6	chr4:48478200-48479400	Weak transcription	Skeletal Muscle Male	skeletal muscle
7	chr4:48478400-48479200	Weak transcription	Osteobl	bone
8	chr4:48478600-48479000	Weak transcription	K562	blood
9	chr4:48479000-48479400	Enhancers	K562	blood
10	chr4:48479200-48480200	Enhancers	Osteobl	bone
11	chr4:48479400-48479800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
12	chr4:48479400-48479800	Flanking Active TSS	K562	blood
13	chr4:48479400-48480000	Enhancers	Cortex derived primary cultured neurospheres	brain
14	chr4:48479400-48481000	Enhancers	Skeletal Muscle Male	skeletal muscle
15	chr4:48479800-48480000	Enhancers	K562	blood
16	chr4:48479800-48484200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
17	chr4:48480000-48483400	Weak transcription	K562	blood
18	chr4:48480000-48484000	Weak transcription	Cortex derived primary cultured neurospheres	brain
19	chr4:48482000-48482200	Enhancers	Brain Germinal Matrix	brain
20	chr4:48483400-48484600	Enhancers	K562	blood
21	chr4:48483600-48484400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr4:48483800-48484000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
23	chr4:48484000-48484800	Enhancers	Cortex derived primary cultured neurospheres	brain
24	chr4:48484200-48484600	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
25	chr4:48484200-48484600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
26	chr4:48484200-48484800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
27	chr4:48484400-48484600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
28	chr4:48484400-48484600	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
29	chr4:48484400-48484800	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
30	chr4:48484400-48484800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
31	chr4:48484400-48484800	Enhancers	A549	lung
32	chr4:48484600-48484800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
33	chr4:48484600-48484800	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
34	chr4:48484600-48485000	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
35	chr4:48484600-48485000	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
36	chr4:48484600-48485000	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
37	chr4:48484600-48485000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
38	chr4:48484600-48485000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
39	chr4:48484600-48485200	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
40	chr4:48484600-48485200	Flanking Active TSS	K562	blood
41	chr4:48484600-48486600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
42	chr4:48484600-48486600	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
43	chr4:48484800-48485000	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
44	chr4:48484800-48485000	Bivalent Enhancer	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
45	chr4:48484800-48485000	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
46	chr4:48484800-48485000	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
47	chr4:48484800-48485000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr4:48484800-48485000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
49	chr4:48484800-48485000	Enhancers	Brain Substantia Nigra	brain
50	chr4:48484800-48485000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links